Clinical trial · Observational
A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas in the Spanish Population
NCT02788916CI-TRIAL-00026534completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to establish the distribution of peripheral T-cell lymphocyte (PTCL) subtypes by re-analysis and re-classification of samples according to the 2008 World Health Organization (WHO) classification of lymphoid neoplasms.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphoma, T-Cell, Peripheral | Lymphoma | ONTOLOGY_EXACT | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No Intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Cohort 1
- description
- Assessment of tumor biopsies and histological preparations of participants diagnosed with peripheral T-cell lymphoma (PTCL) in the six years between 01 January 2008 and 31 December 2013 will be performed.
- interventionNames
- Other: No Intervention
Primary outcomes (1)
- measure
- Distribution of Peripheral T-cell Lymphoma (PTCL) Subtypes
- timeFrame
- Up to 6 months
- description
- Distribution of PTCL subtypes by re-analysis and re-classification of samples according to the 2008 WHO classification of lymphoid neoplasms will be estimated.
Secondary outcomes (8)
- measure
- Percentage of Participants with Each Subtypes of PTCL
- timeFrame
- Up to 6 months
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Participants diagnosed with PTCL in the six years between 01/01/2008 and 31/12/2013. * Availability of initial tumor biopsy diagnosis in paraffin block (node or core biopsy of 16-18mm). * PTCL subtypes permitted by WHO 2008 classification of lymphoid neoplasms: * Natural killer/ T-lymphocytes (NK /T-cell) lymphoma extranodal nasal type * Enteropathic T-cell lymphoma * Hepatosplenic T-cell lymphoma * Peripheral T-cell lymphoma, not otherwise specified * Angioimmunoblastic T-cell lymphoma * Anaplastic large cell lymphoma, Anaplastic lymphoma kinase positive (ALK)+ * Anaplastic large cell lymphoma, ALK- Exclusion Criteria: • Participants with an unavailable history (lost, empty or not recoverable).
References
Publications (0)
Data not yet available
No reference posted for this study.